Pedro L Dago

Grants

Grants per year 2004 2004 2012

• 5 Finished

Grants per year

Search results

• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder

  Gilmer, W. S. & Dago, P. L.

  Cambridge Health Alliance, Janssen Pharmaceutica, Inc.

  10/25/04 → 11/1/11

  Project: Research project

• Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD)

  Gilmer, W. S. & Dago, P. L.

  Aspect Medical Systems, Inc.

  3/1/06 → 1/10/08

  Project: Research project

• Double-Blind, Placebo-Controlled Trial Depakote-ER for Depressive and Anxiety Symptoms in Non-Refractory Bipolar Depression

  Gilmer, W. S. & Dago, P. L.

  Cambridge Health Alliance, Abbott Laboratories

  6/25/04 → 12/31/08

  Project: Research project

• Prot# 44-01101-000: A Randomized, Parallel-Group, Sham-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of The Neuronetics Model 2100 CRS Repetitive Transcranial Magnetic Stimulation (rTMS) System in Patients with Major Depr

  Gilmer, W. S. & Dago, P. L.

  Neuronetics, Inc.

  8/17/04 → 3/12/10

  Project: Research project

• Prot# BAP01346: Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy

  Laumann, A. E., Dago, P. L., Martini, M. C. & West, D. P.

  Covance Periapproval Services, Inc., Basilea Pharmaceutica International Ltd.

  5/26/09 → 5/26/12

  Project: Research project